Nonetheless, as such an antagonism has not been documented in CD8+ T cells, it is plausible that lupus CD8+ T cells employ a distinct molecular mechanism that allows for a dual IL-13- and IFN-γ expression. This evidence concerns the gene CD8A and systemic lupus erythematosus.